Equities

Celadon Pharmaceuticals PLC

CEL:LSE

Celadon Pharmaceuticals PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)92.50
  • Today's Change-5.00 / -5.13%
  • Shares traded14.59k
  • 1 Year change-39.34%
  • Beta-0.0832
Data delayed at least 20 minutes, as of May 20 2024 15:06 BST.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 16-May-24
Select bar for recommendation details.
Recommendations16-May-24
Buy0
Outperform1
Hold0
Underperform0
Sell0

Share price forecast

The 2 analysts offering 12 month price targets for Celadon Pharmaceuticals PLC have a median target of 235.00, with a high estimate of 235.00 and a low estimate of 235.00. The median estimate represents a 154.05% increase from the last price of 92.50.
High154.1%235.00
Med154.1%235.00
Low154.1%235.00
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.